This Government Contract opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Sterile Medical Component Manufacturing

Closed

Federal

Submission Closed07/20/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414

New

SLED

81627Y0875-Purchase of Raboravel V-RG Vaccines

Solicitation # 81627Y0875

The New York City Department of Health and Mental Hygiene (DOHMH) is seeking to establish a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the procurement of RABORAL V-RG coated sachet baits. This licensed oral rabies vaccine is used in the city's baiting program to immunize raccoons and reduce the transmission of rabies to other animals and humans. DOHMH has identified Boehringer Ingelheim as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Under the terms of the agreement, the vendor will provide up to 75,600 individual baits per contract year, sold in quantities of 300. Deliveries must be packed with cold packs and shipped to the NYC Public Health Laboratory at 455 First Avenue, New York, NY 10016, with each shipment accompanied by an invoice. Purchase quantities and delivery schedules will be determined by operational needs, including annual fall baiting campaigns, targeted spring baiting, or emergency responses to rabies outbreaks. Interested firms may submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

Department Of Health And Mental Hygiene

POSTED

DEADLINE

Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)

Solicitation # 12639527R0001

Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.

POSTED

DEADLINE

QPL Polysulfide Sealing Compound Supplier (NSN 8030014796036)This subcontract involves the supply of low-density polysulfide synthetic rubber sealing compound, identified by NSN 8030014796036, for prime contractors under Defense Logistics Agency supply contracts. The material must be gray, include separate catalysts, and strictly conform to SAE Aerospace Material Specification AMS 3281E, Type 1, Class B-1/2. The successful provider is required to maintain QPL-approved manufacturing standards and hold HazMat shipping certifications in accordance with IP025 and 29 CFR 1910.1200. The scope of work requires the delivery of six kits of the sealing compound to Hill AFB in Utah. This procurement falls under NAICS code 325414 and is managed by the Department of Defense. Interested parties must adhere to the specified response deadline of November 2, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Vaccination Campaigns - Procurement of Animal Vaccines.

Solicitation # GC3G2C

The Council for Development and Reconstruction is seeking solicitations for the procurement of animal vaccines to support vaccination campaigns within Lebanon. This federal initiative is managed by the Funding Division, with Oussama Kobeissi serving as the primary point of contact for interested parties. The solicitation, identified by number GC3G2C, was posted on October 22, 2026, and requires responses to be submitted by the deadline of December 3, 2026. All performance of the contract will take place in Lebanon.

Council for Development and Reconstruction

POSTED

DEADLINE

Custom Homing Peptide Synthesis and AAV Capsid ModificationThis subcontract for the Department of Veterans Affairs, specifically supporting the Harry S Truman Memorial Veterans Hospital, involves the synthesis of targeting peptides and genetic engineering services. The scope of work includes designing homing peptides, modifying AAV capsid genomes for peptide display, and producing modified viral vector prototypes. These activities are to be conducted using molecular cloning tools and DNA/RNA synthesis platforms within BSL-2 facilities. The selected provider must hold BSL-2 certification to deliver the required modified AAV vector constructs and synthesized peptide sequences. Performance of the contract will take place in Columbia, Missouri, under NAICS code 325414. The solicitation was posted on October 21, 2026, with a response deadline of November 4, 2026.

POSTED

DEADLINE

Solicitation # SPE2DP-26-R-0001

Solicitation SPE2DP-26-R-0001 is a sole source, firm-fixed price, indefinite delivery, indefinite quantity contract issued by the Defense Logistics Agency for the procurement of Japanese Encephalitis Virus Vaccine (NSN 6505-01-607-7018). The resulting contract will have an eighteen month base term, with a requirement that complete order quantities be delivered FOB Destination to DLA Distribution Susquehanna within 120 days after the date of order. The vaccine must be a purified, inactivated, single-dose prefilled syringe that is FDA approved and serialized in accordance with the Drug Supply Chain Security Act. Strict adherence to Medical Procurement Item Description Number 5 and Medical Marking Standard No. 1D is required, specifically regarding cold chain storage between 2 and 8 degrees Celsius and detailed military packaging and marking standards. Proposals must be submitted electronically via the DLA Internet Bid Board System by November 6, 2026. Award will be based on the most advantageous offer, evaluating FDA approval, supply availability assurance, agreement to all terms without exception, and price. Invoicing and receiving reports must be processed through the Wide Area Workflow system.

Defense Logistics Agency

POSTED

DEADLINE

VAC to Finished Vaccine ConversionThis subcontract involves the conversion of Government-owned Vaccine Antigen Concentrate into final-use Foot and Mouth Disease vaccine doses for prime contractors supporting USDA APHIS projects. The scope of work includes formulating the concentrate into a usable vaccine, performing filling and packaging within cleanroom facilities, and conducting essential final potency and efficacy testing. The project is managed under the Department of Agriculture and will be performed in Ames, Iowa. To be eligible, the contractor must hold a USDA Veterinary Biological Product License. The solicitation was posted on October 1, 2026, with a response deadline of November 10, 2026, falling under NAICS code 325414.

POSTED

DEADLINE

FMD Vaccine Antigen Concentrate (VAC) ProductionThis subcontract for the Department of Agriculture involves the production of Foot and Mouth Disease Vaccine Antigen Concentrates for prime contractors on USDA APHIS projects. The scope of work includes the purification and concentration of VAC serials, which are produced by engineering Master Seed Viruses or utilizing field strains in accordance with 9 CFR Parts 113 and 114. To qualify, the provider must possess a USDA Veterinary Biological Product License and provide propagation cell line data approved by the Center for Veterinary Biologics. The final deliverables are purified and concentrated FMD VAC serials, with performance taking place in Ames, Iowa. The response deadline for this opportunity is November 10, 2026.

POSTED

DEADLINE

Antithrombin III Procurement

Solicitation # CBP-CON-00260

The National Blood Authority is seeking tenders for the procurement of an Antithrombin III product under solicitation number CBP-CON-00260. While the agency currently maintains supply arrangements for Thrombotrol through the National Fractionation Agreement for Australia, this request for tender opens the process for the provision of these essential medical supplies. Interested parties must submit their responses by the deadline of November 20, 2026. All inquiries and submissions should be directed to the CBP Procurement Team via the provided contact email. Further detailed specifications and requirements are contained within the official request for tender documentation.

National Blood Authority

POSTED

DEADLINE

Proteomics and Protein Expression AnalysisThe Proteomics and Protein Expression Analysis subcontract supports National Institutes of Health projects focused on identifying biomarkers related to substance exposure and brain development. The selected provider will perform protein identification and quantification for prime contractors using a variety of high-sensitivity methods, including mass spectrometry, ELISA, Western blotting, and protein-protein interaction assays via LC-MS/MS. To ensure the integrity of the results, the performing laboratory must adhere to ISO/IEC 17025 quality standards. The primary deliverables for this engagement consist of detailed quantitative biomarker reports and comprehensive protein expression profiles. This effort falls under NAICS code 325414 and is managed through the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe Defense Logistics Agency under the Department of Defense has issued a subcontract for the supply of 100 E. coli detection test kits. These diagnostic kits must strictly adhere to FDA regulations, specific shelf-life requirements, and Department of Defense medical packaging standards to ensure quality and viability. Classified under NAICS code 325414, this procurement focuses on the delivery of specialized medical diagnostic tools. The contract was posted on August 11, 2026, and is managed through the DLA's acquisition systems to support military medical readiness.

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Procurement – Petrolatum GauzeThis subcontract with the Defense Logistics Agency under the Department of Defense involves the manufacture or supply of 27 units of petrolatum gauze, identified by NSN 6510-01-112-6414. The procurement falls under NAICS code 325414 and requires all units to meet strict military medical standards. Key delivery requirements include a minimum shelf life of 36 months, with a mandate that the time elapsed from manufacture to delivery does not exceed five months. The contract was posted on August 10, 2026.

Defense Logistics Agency

POSTED

3 months ago

DEADLINE

N/A

AI Contract Overview

The contract involves the manufacture and supply of sterile, single-use medical components including EZ-IO needles, extension sets, and sharps blocks, with full compliance to all applicable regulatory standards. These components are critical for emergency medical procedures and must be produced under stringent quality and sterility controls to ensure patient safety and clinical effectiveness. The work is being solicited as a subcontract under the Department of Defense’s Medical Supply Chain, specifically managed by the MD SURG FSF office, and is classified under NAICS code 325414 for medical and surgical instrument manufacturing. Bids must be submitted by the response deadline of July 20, 2026, and the solicitation was posted on July 14, 2026, with no set-aside provisions specified. Performance is expected to support federal medical operations, though the specific place of performance is not defined. All proposals must demonstrate capability in sterile production, regulatory adherence, and consistent supply chain reliability. Interested parties can access the official solicitation through the provided DIBBS link for full technical and administrative requirements.

General Info

Manufacture and supply sterile medical components for DoD under strict regulatory standards, bid due July 20, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DS-26-T-231F.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

INTRAOSSEOUS INFUSI

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedJul 14

subcontract

Response DeadlineJul 20

Deadline has passed

Submission Closed

07/20/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture and supply sterile, single-use medical components such as EZ-IO needles, extension sets, and sharps blocks with full regulatory compliance.